Fingerprint
Dive into the research topics of 'Rivaroxaban with or without aspirin in stable cardiovascular disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rivaroxaban with or without aspirin in stable cardiovascular disease
COMPASS investigators
- McMaster University
- Institut Universitaire de Cardiologie et Pneumologie de Québec
- Estudios Clínicos Latino America and Instituto Cardiovascular de Rosario
- Amphia Ziekenhuis and Werkgroep Cardiologische Centra Nederland (WCN)
- Charles University
- Osaka Prefectural Hospital Organization
- Instituto Dante Pazzanese de Cardiologia
- Hospital do Coração
- University of Washington
- Harvard University
- Chinese Academy of Medical Sciences
- Associazione Nazionale Medici Cardiologi Ospedalieri
- Fundación Oftalmológica de Santander
- University of Galway
- University College London
- University of Edinburgh
- Ukrainian Institute of Cardiology
- University of Würzburg
- Semmelweis University
- Karolinska Institutet
- Russian Ministry of Health
- University of the Philippines
- Universidad de la Frontera
- University of Cape Town
- Aalborg University
- University of Glasgow
- Collegium Medicum Jagiellonian University
- KU Leuven
- Carol Davila University of Medicine and Pharmacy
- The Catholic University of Korea
- Monash University
- Carmel Medical Center
- Universidad Tecnológica Equinoccial
- Universiti Teknologi MARA
- Université Paris Cité
- University of Turku
- Bayer AG
Research output: Contribution to journal › Article › peer-review
2094
Scopus
citations